Retrophin, LLC to Present at Biotech Showcase 2013  
12/27/2012 6:51:10 AM

NEW YORK--(BUSINESS WIRE)--Retrophin (OTCQB: RTRX), a biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases, today announced that Martin Shkreli, Founder & Chief Executive Officer, will be presenting at Biotech Showcase™ 2013, which is being held January 7-9, 2013 in San Francisco, CA. Shkreli will discuss the company’s recent reverse merger and upcoming clinical milestones, including enrollment in a potentially pivotal Phase II clinical trial of Retrophin’s lead compound, RE-021.